Blue sweat: Infectious Pseudochromdrosis Caused by Bacillus Cereus

Sponsor
Oslo University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05507086
Collaborator
(none)
12
1
48
0.3

Study Details

Study Description

Brief Summary

Twelve patients with blue sweat (infectious pseudochromhidrosis) caused by Bacillus cereus.

Condition or Disease Intervention/Treatment Phase
  • Other: Antimicrobial therapy

Detailed Description

Case series/observational study. Twelve patients with blue sweat (infectious pseudochromhidrosis) caused by Bacillus cereus. Demography, clinical presentation, diagnosis, treatments, microbiology and causality.

Study Design

Study Type:
Observational
Anticipated Enrollment :
12 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Blue Sweat - Infectious Pseudochromdrosis Caused by Bacillus Cereus
Actual Study Start Date :
Jan 1, 2020
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2023

Outcome Measures

Primary Outcome Measures

  1. Remission [1 year]

    Descriptive / physical examination

  2. Repeated bacteriological swab [1 year]

    Repeated bacteriological swab if uncertainty in terms of complete remission

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Infectious pseudochromhidrosis caused by Bacillus cereus
Exclusion Criteria:
  • Other types of blue chromhidrosis

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Microbiology Lørenskog Viken Norway 1478

Sponsors and Collaborators

  • Oslo University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Christoffer Aam Ingvaldsen, Researcher, University Hospital, Akershus
ClinicalTrials.gov Identifier:
NCT05507086
Other Study ID Numbers:
  • IPCH2
First Posted:
Aug 18, 2022
Last Update Posted:
Aug 23, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Christoffer Aam Ingvaldsen, Researcher, University Hospital, Akershus
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 23, 2022